placeholder newsslider


Ukrainian scientists fear for their lives and future amid Russian threat

Researchers say that conflict will hinder progress made since Ukraine’s revolution in 2014.

25th anniversary of the demonstration of adaptive optics in the Human Eye

The journal Biomedical Optics Express, published by Optica (formerly OSA), announced a special issue on “Adaptive Optics for Biomedical Applications.”

Medicare cuts, ASC rates, new FDA-approved drugs: Latest for 2022

Medicare payment changes, ASC payment rates and new FDA approved drugs were a few of the topics discussed in a presentation on 2022 updates for ophthalmic practices at Hawaiian Eye 2022.

Robert E. Wiggins Jr., MD, Gifted Physician and Practice Administrator, to Lead the American Academy of Ophthalmology in 2022

North Carolina physician vows to support and guide members through workforce and reimbursement challenges

UCL IoO Annual Review for 2020-2021 academic year now live

We are delighted to launch our annual review for the last academic year.

Virtual reality archery is "braille" for orientation of blind people

Researchers at the IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) developed an acoustic virtual reality-based archery game, enabling blind people to experience for the first time this type of technology, which is typically focused on vision.

UCL IoO’s Honorary Professor recognised in 2022 New Year’s Honours

Congratulations to Mr Ian Murdoch for receiving an MBE in the New Year honours.

Horizon NEURON project @IOB

Daniel Hillier, leader of the IOB non-human primate platform, just won a Horizon NEURON grant totalling 1.2 million Euro for an amblyopia project.

U.K. and Swiss researchers left in limbo with European grants

Restrictions on first grants from Horizon Europe highlight ongoing diplomatic disputes

Science's 2021 Breakthrough of the Year

Researchers have shown that artificial intelligence (AI)-driven software can churn out accurate protein structures by the thousands—an advance and is Science’s 2021 Breakthrough of the Year.

New technology streamlines the development of gene therapy for genetic blinding disorders

A novel computational platform developed by researchers from the University of Pittsburgh School of Medicine identifies top-performing viral vectors that could deliver gene therapies to the retina with maximum efficiency and precision.

Alcon to acquire Ivantis for $475 million

Alcon announced plans to acquire glaucoma surgery device maker Ivantis in a $475 million deal.

New kind of artificial lens may help patients avoid glasses after cataract surgery

Cataract surgery is one of the most successful medical procedures performed in the United States, with nearly 4 million Americans choosing to have their cataracts removed every year. While the procedure has a success rate of about 97 percent, it is not uncommon for people to still need glasses after surgery, especially reading glasses.

2021 Best Program results: Wilmer Eye Institute grabs top spot

The year 2021 saw the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, snaring the top spot in the Overall Best Program category.

RetinAward 2021 for Mathieu Quinodoz

Mathieu Quinodoz, bioinformatics researcher in our Ophthalmic Genetics Group led by Carlo Rivolta, wins CHF 30 000 to support his project: «Increasing the molecular diagnostic rate of inherited retinal degenerations and other retinal diseases by combining high-throughput sequencing with an extensive analytical pipeline».